nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—telencephalon—malignant glioma	0.0228	0.0849	CbGeAlD
Octreotide—SSTR5—brainstem—malignant glioma	0.0219	0.0814	CbGeAlD
Octreotide—SSTR3—brainstem—malignant glioma	0.021	0.078	CbGeAlD
Octreotide—SSTR1—brainstem—malignant glioma	0.0166	0.0617	CbGeAlD
Octreotide—SSTR1—telencephalon—malignant glioma	0.0147	0.0547	CbGeAlD
Octreotide—SSTR2—brainstem—malignant glioma	0.0141	0.0524	CbGeAlD
Octreotide—SSTR4—central nervous system—malignant glioma	0.013	0.0483	CbGeAlD
Octreotide—SSTR2—telencephalon—malignant glioma	0.0125	0.0465	CbGeAlD
Octreotide—SSTR5—cerebellum—malignant glioma	0.0108	0.0401	CbGeAlD
Octreotide—MPO—endothelium—malignant glioma	0.0106	0.0394	CbGeAlD
Octreotide—SSTR3—central nervous system—malignant glioma	0.0106	0.0393	CbGeAlD
Octreotide—SSTR1—midbrain—malignant glioma	0.0106	0.0393	CbGeAlD
Octreotide—SSTR3—cerebellum—malignant glioma	0.0103	0.0385	CbGeAlD
Octreotide—SSTR4—brain—malignant glioma	0.0103	0.0383	CbGeAlD
Octreotide—MPO—blood vessel—malignant glioma	0.00976	0.0363	CbGeAlD
Octreotide—SSTR3—brain—malignant glioma	0.0084	0.0312	CbGeAlD
Octreotide—SSTR1—central nervous system—malignant glioma	0.00836	0.0311	CbGeAlD
Octreotide—Clotting—Temozolomide—malignant glioma	0.00833	0.0265	CcSEcCtD
Octreotide—SSTR1—cerebellum—malignant glioma	0.00817	0.0304	CbGeAlD
Octreotide—VIIth nerve paralysis—Carmustine—malignant glioma	0.00751	0.0238	CcSEcCtD
Octreotide—SSTR2—central nervous system—malignant glioma	0.00711	0.0264	CbGeAlD
Octreotide—SSTR2—cerebellum—malignant glioma	0.00695	0.0258	CbGeAlD
Octreotide—SSTR1—brain—malignant glioma	0.00664	0.0247	CbGeAlD
Octreotide—SSTR2—brain—malignant glioma	0.00564	0.021	CbGeAlD
Octreotide—Transaminases increased—Carmustine—malignant glioma	0.00506	0.0161	CcSEcCtD
Octreotide—Haemorrhoids—Temozolomide—malignant glioma	0.00506	0.0161	CcSEcCtD
Octreotide—Paranoia—Carmustine—malignant glioma	0.00452	0.0143	CcSEcCtD
Octreotide—Burning sensation—Carmustine—malignant glioma	0.00443	0.0141	CcSEcCtD
Octreotide—Influenza-like symptoms—Temozolomide—malignant glioma	0.00417	0.0132	CcSEcCtD
Octreotide—Herpes zoster—Temozolomide—malignant glioma	0.00395	0.0126	CcSEcCtD
Octreotide—Cholestasis—Temozolomide—malignant glioma	0.00392	0.0124	CcSEcCtD
Octreotide—Otitis media—Temozolomide—malignant glioma	0.00382	0.0121	CcSEcCtD
Octreotide—Coagulopathy—Temozolomide—malignant glioma	0.00382	0.0121	CcSEcCtD
Octreotide—Injection site pain—Carmustine—malignant glioma	0.00377	0.012	CcSEcCtD
Octreotide—Petechiae—Temozolomide—malignant glioma	0.00362	0.0115	CcSEcCtD
Octreotide—Endocrine disorder—Temozolomide—malignant glioma	0.00359	0.0114	CcSEcCtD
Octreotide—Extravasation—Carmustine—malignant glioma	0.00353	0.0112	CcSEcCtD
Octreotide—Breast pain—Temozolomide—malignant glioma	0.00341	0.0108	CcSEcCtD
Octreotide—Amenorrhoea—Temozolomide—malignant glioma	0.00339	0.0108	CcSEcCtD
Octreotide—Drug interaction—Carmustine—malignant glioma	0.00332	0.0105	CcSEcCtD
Octreotide—MPO—spinal cord—malignant glioma	0.00332	0.0123	CbGeAlD
Octreotide—Viral infection—Temozolomide—malignant glioma	0.00329	0.0105	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00327	0.0104	CcSEcCtD
Octreotide—Herpes simplex—Temozolomide—malignant glioma	0.00323	0.0103	CcSEcCtD
Octreotide—Hearing impaired—Temozolomide—malignant glioma	0.00313	0.00993	CcSEcCtD
Octreotide—Injection site reaction—Carmustine—malignant glioma	0.00306	0.00972	CcSEcCtD
Octreotide—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00298	0.00945	CcSEcCtD
Octreotide—Vaginal inflammation—Temozolomide—malignant glioma	0.00298	0.00945	CcSEcCtD
Octreotide—Candida infection—Carmustine—malignant glioma	0.00294	0.00934	CcSEcCtD
Octreotide—Neuropathy—Carmustine—malignant glioma	0.00289	0.00918	CcSEcCtD
Octreotide—Influenza like illness—Temozolomide—malignant glioma	0.00289	0.00918	CcSEcCtD
Octreotide—Candida infection—Temozolomide—malignant glioma	0.00284	0.00902	CcSEcCtD
Octreotide—Vaginal infection—Temozolomide—malignant glioma	0.00281	0.00892	CcSEcCtD
Octreotide—Neuropathy—Temozolomide—malignant glioma	0.00279	0.00887	CcSEcCtD
Octreotide—Gynaecomastia—Carmustine—malignant glioma	0.00276	0.00875	CcSEcCtD
Octreotide—MPO—central nervous system—malignant glioma	0.00269	0.01	CbGeAlD
Octreotide—Phlebitis—Carmustine—malignant glioma	0.00259	0.00824	CcSEcCtD
Octreotide—Thrombophlebitis—Carmustine—malignant glioma	0.00258	0.0082	CcSEcCtD
Octreotide—Diabetes mellitus—Carmustine—malignant glioma	0.00257	0.00816	CcSEcCtD
Octreotide—Thrombophlebitis—Temozolomide—malignant glioma	0.0025	0.00793	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00248	0.00789	CcSEcCtD
Octreotide—Gastroenteritis—Temozolomide—malignant glioma	0.00244	0.00774	CcSEcCtD
Octreotide—Injury—Carmustine—malignant glioma	0.00243	0.00772	CcSEcCtD
Octreotide—Deafness—Temozolomide—malignant glioma	0.00241	0.00767	CcSEcCtD
Octreotide—Amnesia—Carmustine—malignant glioma	0.00238	0.00756	CcSEcCtD
Octreotide—Nasal congestion—Temozolomide—malignant glioma	0.00237	0.00753	CcSEcCtD
Octreotide—Hot flush—Temozolomide—malignant glioma	0.00231	0.00733	CcSEcCtD
Octreotide—Amnesia—Temozolomide—malignant glioma	0.0023	0.0073	CcSEcCtD
Octreotide—Menopausal symptoms—Temozolomide—malignant glioma	0.00229	0.00727	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00224	0.0071	CcSEcCtD
Octreotide—MPO—brain—malignant glioma	0.00214	0.00795	CbGeAlD
Octreotide—Dehydration—Temozolomide—malignant glioma	0.00201	0.00638	CcSEcCtD
Octreotide—Dry skin—Temozolomide—malignant glioma	0.00198	0.00629	CcSEcCtD
Octreotide—Muscular weakness—Carmustine—malignant glioma	0.00197	0.00626	CcSEcCtD
Octreotide—Muscular weakness—Temozolomide—malignant glioma	0.00191	0.00605	CcSEcCtD
Octreotide—Abdominal distension—Temozolomide—malignant glioma	0.00188	0.00597	CcSEcCtD
Octreotide—Sweating increased—Temozolomide—malignant glioma	0.00182	0.00578	CcSEcCtD
Octreotide—Bronchitis—Temozolomide—malignant glioma	0.0018	0.0057	CcSEcCtD
Octreotide—Desmopressin—PTGS1—malignant glioma	0.00177	0.636	CrCbGaD
Octreotide—Dysuria—Temozolomide—malignant glioma	0.00175	0.00555	CcSEcCtD
Octreotide—Hyperglycaemia—Carmustine—malignant glioma	0.00174	0.00554	CcSEcCtD
Octreotide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00174	0.00551	CcSEcCtD
Octreotide—Pneumonia—Carmustine—malignant glioma	0.00173	0.0055	CcSEcCtD
Octreotide—Pollakiuria—Temozolomide—malignant glioma	0.00172	0.00548	CcSEcCtD
Octreotide—Depression—Carmustine—malignant glioma	0.00172	0.00546	CcSEcCtD
Octreotide—Weight increased—Temozolomide—malignant glioma	0.0017	0.0054	CcSEcCtD
Octreotide—Weight decreased—Temozolomide—malignant glioma	0.00169	0.00537	CcSEcCtD
Octreotide—Neuropathy peripheral—Carmustine—malignant glioma	0.00169	0.00536	CcSEcCtD
Octreotide—Hyperglycaemia—Temozolomide—malignant glioma	0.00168	0.00535	CcSEcCtD
Octreotide—Urinary tract infection—Carmustine—malignant glioma	0.00167	0.00532	CcSEcCtD
Octreotide—Pneumonia—Temozolomide—malignant glioma	0.00167	0.00532	CcSEcCtD
Octreotide—Depression—Temozolomide—malignant glioma	0.00166	0.00527	CcSEcCtD
Octreotide—Neuropathy peripheral—Temozolomide—malignant glioma	0.00163	0.00518	CcSEcCtD
Octreotide—Urinary tract infection—Temozolomide—malignant glioma	0.00162	0.00514	CcSEcCtD
Octreotide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00157	0.005	CcSEcCtD
Octreotide—Sinusitis—Temozolomide—malignant glioma	0.00156	0.00496	CcSEcCtD
Octreotide—Hypoaesthesia—Carmustine—malignant glioma	0.00154	0.00489	CcSEcCtD
Octreotide—Oedema peripheral—Carmustine—malignant glioma	0.00152	0.00484	CcSEcCtD
Octreotide—Hepatitis—Temozolomide—malignant glioma	0.00149	0.00475	CcSEcCtD
Octreotide—Visual impairment—Carmustine—malignant glioma	0.00149	0.00473	CcSEcCtD
Octreotide—Hypoaesthesia—Temozolomide—malignant glioma	0.00149	0.00472	CcSEcCtD
Octreotide—Pharyngitis—Temozolomide—malignant glioma	0.00148	0.00471	CcSEcCtD
Octreotide—Oedema peripheral—Temozolomide—malignant glioma	0.00147	0.00468	CcSEcCtD
Octreotide—Visual impairment—Temozolomide—malignant glioma	0.00144	0.00457	CcSEcCtD
Octreotide—Flushing—Carmustine—malignant glioma	0.00144	0.00456	CcSEcCtD
Octreotide—Tinnitus—Temozolomide—malignant glioma	0.00139	0.00443	CcSEcCtD
Octreotide—Flushing—Temozolomide—malignant glioma	0.00139	0.00441	CcSEcCtD
Octreotide—Cardiac disorder—Temozolomide—malignant glioma	0.00139	0.00441	CcSEcCtD
Octreotide—Arrhythmia—Carmustine—malignant glioma	0.00138	0.00439	CcSEcCtD
Octreotide—Alopecia—Carmustine—malignant glioma	0.00137	0.00434	CcSEcCtD
Octreotide—Mental disorder—Carmustine—malignant glioma	0.00135	0.0043	CcSEcCtD
Octreotide—Immune system disorder—Temozolomide—malignant glioma	0.00135	0.00429	CcSEcCtD
Octreotide—Malnutrition—Carmustine—malignant glioma	0.00135	0.00428	CcSEcCtD
Octreotide—Erythema—Carmustine—malignant glioma	0.00135	0.00428	CcSEcCtD
Octreotide—Alopecia—Temozolomide—malignant glioma	0.00132	0.00419	CcSEcCtD
Octreotide—Mental disorder—Temozolomide—malignant glioma	0.00131	0.00416	CcSEcCtD
Octreotide—Back pain—Carmustine—malignant glioma	0.0013	0.00414	CcSEcCtD
Octreotide—Malnutrition—Temozolomide—malignant glioma	0.0013	0.00413	CcSEcCtD
Octreotide—Erythema—Temozolomide—malignant glioma	0.0013	0.00413	CcSEcCtD
Octreotide—Vision blurred—Carmustine—malignant glioma	0.00127	0.00403	CcSEcCtD
Octreotide—Tremor—Carmustine—malignant glioma	0.00126	0.00401	CcSEcCtD
Octreotide—Back pain—Temozolomide—malignant glioma	0.00126	0.004	CcSEcCtD
Octreotide—Anaemia—Carmustine—malignant glioma	0.00124	0.00395	CcSEcCtD
Octreotide—Agitation—Carmustine—malignant glioma	0.00124	0.00393	CcSEcCtD
Octreotide—Vision blurred—Temozolomide—malignant glioma	0.00123	0.00389	CcSEcCtD
Octreotide—Tremor—Temozolomide—malignant glioma	0.00122	0.00387	CcSEcCtD
Octreotide—Ill-defined disorder—Temozolomide—malignant glioma	0.00121	0.00383	CcSEcCtD
Octreotide—Anaemia—Temozolomide—malignant glioma	0.0012	0.00382	CcSEcCtD
Octreotide—Agitation—Temozolomide—malignant glioma	0.0012	0.0038	CcSEcCtD
Octreotide—Malaise—Temozolomide—malignant glioma	0.00117	0.00373	CcSEcCtD
Octreotide—Vertigo—Temozolomide—malignant glioma	0.00117	0.00371	CcSEcCtD
Octreotide—Convulsion—Carmustine—malignant glioma	0.00117	0.0037	CcSEcCtD
Octreotide—Hypertension—Carmustine—malignant glioma	0.00116	0.00369	CcSEcCtD
Octreotide—Palpitations—Temozolomide—malignant glioma	0.00115	0.00365	CcSEcCtD
Octreotide—Chest pain—Carmustine—malignant glioma	0.00115	0.00364	CcSEcCtD
Octreotide—Myalgia—Carmustine—malignant glioma	0.00115	0.00364	CcSEcCtD
Octreotide—Anxiety—Carmustine—malignant glioma	0.00114	0.00363	CcSEcCtD
Octreotide—Cough—Temozolomide—malignant glioma	0.00114	0.00361	CcSEcCtD
Octreotide—Convulsion—Temozolomide—malignant glioma	0.00113	0.00358	CcSEcCtD
Octreotide—Hypertension—Temozolomide—malignant glioma	0.00112	0.00357	CcSEcCtD
Octreotide—Arthralgia—Temozolomide—malignant glioma	0.00111	0.00352	CcSEcCtD
Octreotide—Myalgia—Temozolomide—malignant glioma	0.00111	0.00352	CcSEcCtD
Octreotide—Anxiety—Temozolomide—malignant glioma	0.0011	0.00351	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0011	0.00349	CcSEcCtD
Octreotide—Oedema—Carmustine—malignant glioma	0.0011	0.00349	CcSEcCtD
Octreotide—Discomfort—Temozolomide—malignant glioma	0.00109	0.00348	CcSEcCtD
Octreotide—Infection—Carmustine—malignant glioma	0.00109	0.00347	CcSEcCtD
Octreotide—Dry mouth—Temozolomide—malignant glioma	0.00108	0.00344	CcSEcCtD
Octreotide—Thrombocytopenia—Carmustine—malignant glioma	0.00108	0.00342	CcSEcCtD
Octreotide—Tachycardia—Carmustine—malignant glioma	0.00107	0.00341	CcSEcCtD
Octreotide—Anaphylactic shock—Temozolomide—malignant glioma	0.00106	0.00337	CcSEcCtD
Octreotide—Oedema—Temozolomide—malignant glioma	0.00106	0.00337	CcSEcCtD
Octreotide—Infection—Temozolomide—malignant glioma	0.00105	0.00335	CcSEcCtD
Octreotide—Anorexia—Carmustine—malignant glioma	0.00105	0.00333	CcSEcCtD
Octreotide—Nervous system disorder—Temozolomide—malignant glioma	0.00104	0.00331	CcSEcCtD
Octreotide—Thrombocytopenia—Temozolomide—malignant glioma	0.00104	0.0033	CcSEcCtD
Octreotide—Skin disorder—Temozolomide—malignant glioma	0.00103	0.00328	CcSEcCtD
Octreotide—Hyperhidrosis—Temozolomide—malignant glioma	0.00103	0.00326	CcSEcCtD
Octreotide—Anorexia—Temozolomide—malignant glioma	0.00101	0.00321	CcSEcCtD
Octreotide—Desmopressin—PTGS2—malignant glioma	0.00101	0.364	CrCbGaD
Octreotide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.001	0.00318	CcSEcCtD
Octreotide—Insomnia—Carmustine—malignant glioma	0.000994	0.00316	CcSEcCtD
Octreotide—Paraesthesia—Carmustine—malignant glioma	0.000987	0.00313	CcSEcCtD
Octreotide—Dyspnoea—Carmustine—malignant glioma	0.00098	0.00311	CcSEcCtD
Octreotide—Somnolence—Carmustine—malignant glioma	0.000977	0.0031	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000967	0.00307	CcSEcCtD
Octreotide—Insomnia—Temozolomide—malignant glioma	0.00096	0.00305	CcSEcCtD
Octreotide—Decreased appetite—Carmustine—malignant glioma	0.000955	0.00303	CcSEcCtD
Octreotide—Paraesthesia—Temozolomide—malignant glioma	0.000953	0.00303	CcSEcCtD
Octreotide—Gastrointestinal disorder—Carmustine—malignant glioma	0.000949	0.00301	CcSEcCtD
Octreotide—Dyspnoea—Temozolomide—malignant glioma	0.000947	0.00301	CcSEcCtD
Octreotide—Somnolence—Temozolomide—malignant glioma	0.000944	0.003	CcSEcCtD
Octreotide—Constipation—Carmustine—malignant glioma	0.00094	0.00298	CcSEcCtD
Octreotide—Pain—Carmustine—malignant glioma	0.00094	0.00298	CcSEcCtD
Octreotide—Dyspepsia—Temozolomide—malignant glioma	0.000935	0.00297	CcSEcCtD
Octreotide—Decreased appetite—Temozolomide—malignant glioma	0.000923	0.00293	CcSEcCtD
Octreotide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000917	0.00291	CcSEcCtD
Octreotide—Fatigue—Temozolomide—malignant glioma	0.000915	0.00291	CcSEcCtD
Octreotide—Pain—Temozolomide—malignant glioma	0.000908	0.00288	CcSEcCtD
Octreotide—Constipation—Temozolomide—malignant glioma	0.000908	0.00288	CcSEcCtD
Octreotide—Feeling abnormal—Carmustine—malignant glioma	0.000905	0.00288	CcSEcCtD
Octreotide—Gastrointestinal pain—Carmustine—malignant glioma	0.000898	0.00285	CcSEcCtD
Octreotide—Feeling abnormal—Temozolomide—malignant glioma	0.000875	0.00278	CcSEcCtD
Octreotide—Abdominal pain—Carmustine—malignant glioma	0.000869	0.00276	CcSEcCtD
Octreotide—Body temperature increased—Carmustine—malignant glioma	0.000869	0.00276	CcSEcCtD
Octreotide—Gastrointestinal pain—Temozolomide—malignant glioma	0.000868	0.00276	CcSEcCtD
Octreotide—Urticaria—Temozolomide—malignant glioma	0.000843	0.00268	CcSEcCtD
Octreotide—Body temperature increased—Temozolomide—malignant glioma	0.000839	0.00267	CcSEcCtD
Octreotide—Abdominal pain—Temozolomide—malignant glioma	0.000839	0.00267	CcSEcCtD
Octreotide—Hypersensitivity—Carmustine—malignant glioma	0.000809	0.00257	CcSEcCtD
Octreotide—Asthenia—Carmustine—malignant glioma	0.000788	0.0025	CcSEcCtD
Octreotide—Hypersensitivity—Temozolomide—malignant glioma	0.000782	0.00248	CcSEcCtD
Octreotide—Asthenia—Temozolomide—malignant glioma	0.000762	0.00242	CcSEcCtD
Octreotide—Diarrhoea—Carmustine—malignant glioma	0.000752	0.00239	CcSEcCtD
Octreotide—Pruritus—Temozolomide—malignant glioma	0.000751	0.00239	CcSEcCtD
Octreotide—Dizziness—Carmustine—malignant glioma	0.000727	0.00231	CcSEcCtD
Octreotide—Diarrhoea—Temozolomide—malignant glioma	0.000726	0.00231	CcSEcCtD
Octreotide—Dizziness—Temozolomide—malignant glioma	0.000702	0.00223	CcSEcCtD
Octreotide—Vomiting—Carmustine—malignant glioma	0.000699	0.00222	CcSEcCtD
Octreotide—Rash—Carmustine—malignant glioma	0.000693	0.0022	CcSEcCtD
Octreotide—Dermatitis—Carmustine—malignant glioma	0.000692	0.0022	CcSEcCtD
Octreotide—Headache—Carmustine—malignant glioma	0.000688	0.00219	CcSEcCtD
Octreotide—Vomiting—Temozolomide—malignant glioma	0.000675	0.00214	CcSEcCtD
Octreotide—Rash—Temozolomide—malignant glioma	0.000669	0.00213	CcSEcCtD
Octreotide—Dermatitis—Temozolomide—malignant glioma	0.000669	0.00212	CcSEcCtD
Octreotide—Headache—Temozolomide—malignant glioma	0.000665	0.00211	CcSEcCtD
Octreotide—Nausea—Carmustine—malignant glioma	0.000653	0.00207	CcSEcCtD
Octreotide—Nausea—Temozolomide—malignant glioma	0.000631	0.002	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000185	0.000447	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2—malignant glioma	0.000184	0.000446	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NTRK1—malignant glioma	0.000184	0.000445	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTPN11—malignant glioma	0.000183	0.000443	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGF—malignant glioma	0.000183	0.000443	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HES1—malignant glioma	0.000182	0.000441	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CB—malignant glioma	0.000182	0.000441	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTPN11—malignant glioma	0.000182	0.00044	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH2—malignant glioma	0.000182	0.00044	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NCOR1—malignant glioma	0.000181	0.000439	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PDGFRA—malignant glioma	0.000181	0.000438	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000181	0.000437	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—RAF1—malignant glioma	0.000179	0.000433	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KNG1—malignant glioma	0.000178	0.000431	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CD—malignant glioma	0.000178	0.00043	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—malignant glioma	0.000177	0.000427	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—malignant glioma	0.000176	0.000425	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—malignant glioma	0.000175	0.000424	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000175	0.000423	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—BRAF—malignant glioma	0.000174	0.000421	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PDGFRA—malignant glioma	0.000174	0.00042	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP3—malignant glioma	0.000171	0.000414	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT2—malignant glioma	0.000171	0.000413	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CB—malignant glioma	0.000171	0.000413	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NTRK1—malignant glioma	0.00017	0.000411	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN2B—malignant glioma	0.00017	0.00041	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT2—malignant glioma	0.00017	0.00041	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—malignant glioma	0.000169	0.000408	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—malignant glioma	0.000169	0.000408	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—malignant glioma	0.000168	0.000406	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2—malignant glioma	0.000167	0.000405	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TERT—malignant glioma	0.000167	0.000403	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTK2—malignant glioma	0.000165	0.000398	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CD—malignant glioma	0.000164	0.000397	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—malignant glioma	0.000164	0.000397	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CD—malignant glioma	0.000163	0.000394	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PDGFB—malignant glioma	0.000163	0.000394	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGFR1—malignant glioma	0.000162	0.000392	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HES1—malignant glioma	0.000162	0.000391	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—malignant glioma	0.000161	0.00039	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NCOR1—malignant glioma	0.000161	0.000389	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2—malignant glioma	0.00016	0.000388	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TERT—malignant glioma	0.00016	0.000387	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—malignant glioma	0.00016	0.000386	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HIF1A—malignant glioma	0.000159	0.000386	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RAF1—malignant glioma	0.000159	0.000384	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP3—malignant glioma	0.000158	0.000382	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000157	0.000381	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—malignant glioma	0.000157	0.000379	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN2B—malignant glioma	0.000157	0.000379	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGF2—malignant glioma	0.000156	0.000377	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PDGFB—malignant glioma	0.000156	0.000377	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGFR1—malignant glioma	0.000155	0.000375	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CB—malignant glioma	0.000155	0.000375	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CAV1—malignant glioma	0.000154	0.000373	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PDGFRA—malignant glioma	0.000154	0.000373	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HIF1A—malignant glioma	0.000153	0.00037	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—malignant glioma	0.000153	0.000369	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTK2—malignant glioma	0.000152	0.000368	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—malignant glioma	0.000151	0.000366	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SPP1—malignant glioma	0.00015	0.000362	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HES1—malignant glioma	0.000149	0.000361	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—malignant glioma	0.000149	0.00036	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NCOR1—malignant glioma	0.000148	0.000359	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CAV1—malignant glioma	0.000148	0.000358	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—F2—malignant glioma	0.000147	0.000355	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FN1—malignant glioma	0.000147	0.000355	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—malignant glioma	0.000147	0.000355	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RAF1—malignant glioma	0.000146	0.000354	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—malignant glioma	0.000146	0.000354	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MDM2—malignant glioma	0.000146	0.000353	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAF1—malignant glioma	0.000146	0.000352	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BAD—malignant glioma	0.000145	0.000351	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—malignant glioma	0.000145	0.00035	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB2—malignant glioma	0.000144	0.000348	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOTCH1—malignant glioma	0.000144	0.000347	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—malignant glioma	0.000143	0.000346	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—malignant glioma	0.000142	0.000344	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFRA—malignant glioma	0.000142	0.000344	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—malignant glioma	0.000142	0.000344	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—malignant glioma	0.000142	0.000343	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—F2—malignant glioma	0.000141	0.00034	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FN1—malignant glioma	0.000141	0.00034	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD80—malignant glioma	0.000141	0.00034	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—malignant glioma	0.000141	0.00034	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—malignant glioma	0.000141	0.00034	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BAD—malignant glioma	0.000139	0.000336	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGF—malignant glioma	0.000139	0.000336	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PDGFB—malignant glioma	0.000138	0.000335	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTPN11—malignant glioma	0.000138	0.000334	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—malignant glioma	0.000138	0.000334	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH1—malignant glioma	0.000138	0.000333	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGFR1—malignant glioma	0.000138	0.000333	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—malignant glioma	0.000137	0.000332	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—malignant glioma	0.000137	0.00033	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—malignant glioma	0.000136	0.000328	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CD80—malignant glioma	0.000135	0.000326	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—malignant glioma	0.000135	0.000326	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—malignant glioma	0.000135	0.000326	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGF—malignant glioma	0.000133	0.000322	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTPN11—malignant glioma	0.000132	0.00032	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BRAF—malignant glioma	0.000132	0.000319	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—malignant glioma	0.000132	0.000319	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—malignant glioma	0.000131	0.000318	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CAV1—malignant glioma	0.000131	0.000317	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—malignant glioma	0.000131	0.000316	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—malignant glioma	0.000131	0.000316	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—malignant glioma	0.00013	0.000316	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—malignant glioma	0.00013	0.000314	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT2—malignant glioma	0.000129	0.000311	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—malignant glioma	0.000128	0.00031	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFB—malignant glioma	0.000128	0.000309	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGFR1—malignant glioma	0.000127	0.000307	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—malignant glioma	0.000127	0.000306	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIF1A—malignant glioma	0.000125	0.000303	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—F2—malignant glioma	0.000125	0.000302	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FN1—malignant glioma	0.000125	0.000302	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—malignant glioma	0.000124	0.000299	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—malignant glioma	0.000123	0.000299	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BAD—malignant glioma	0.000123	0.000298	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT2—malignant glioma	0.000123	0.000298	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—malignant glioma	0.000123	0.000297	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—malignant glioma	0.000123	0.000297	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—malignant glioma	0.000122	0.000296	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH1—malignant glioma	0.000122	0.000295	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CAV1—malignant glioma	0.000121	0.000293	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—malignant glioma	0.000121	0.000292	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—malignant glioma	0.00012	0.00029	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—malignant glioma	0.00012	0.000289	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CD80—malignant glioma	0.00012	0.000289	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—malignant glioma	0.000119	0.000289	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—malignant glioma	0.000119	0.000289	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—malignant glioma	0.000118	0.000286	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGF2—malignant glioma	0.000118	0.000286	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGF—malignant glioma	0.000118	0.000286	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTPN11—malignant glioma	0.000117	0.000284	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000117	0.000284	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—malignant glioma	0.000116	0.00028	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—F2—malignant glioma	0.000115	0.000279	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FN1—malignant glioma	0.000115	0.000279	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BAD—malignant glioma	0.000114	0.000275	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGF2—malignant glioma	0.000113	0.000274	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH1—malignant glioma	0.000113	0.000273	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BRAF—malignant glioma	0.000112	0.000272	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—malignant glioma	0.000111	0.000269	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—malignant glioma	0.000111	0.000268	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MDM2—malignant glioma	0.000111	0.000268	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD80—malignant glioma	0.00011	0.000267	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAF1—malignant glioma	0.00011	0.000267	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—malignant glioma	0.00011	0.000267	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—malignant glioma	0.00011	0.000267	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—malignant glioma	0.00011	0.000266	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT2—malignant glioma	0.000109	0.000264	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—malignant glioma	0.000109	0.000264	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGF—malignant glioma	0.000109	0.000264	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—malignant glioma	0.000109	0.000263	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTPN11—malignant glioma	0.000108	0.000262	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—malignant glioma	0.000108	0.00026	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—malignant glioma	0.000107	0.000258	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MDM2—malignant glioma	0.000106	0.000257	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAF1—malignant glioma	0.000106	0.000256	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—malignant glioma	0.000105	0.000254	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB2—malignant glioma	0.000105	0.000253	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—malignant glioma	0.000104	0.000252	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—malignant glioma	0.000104	0.000251	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—malignant glioma	0.000103	0.00025	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—malignant glioma	0.000103	0.00025	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—malignant glioma	0.000103	0.000249	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—malignant glioma	0.000102	0.000247	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT2—malignant glioma	0.000101	0.000244	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF2—malignant glioma	0.000101	0.000243	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—malignant glioma	0.0001	0.000243	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—malignant glioma	0.0001	0.000242	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—malignant glioma	9.98e-05	0.000241	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—malignant glioma	9.92e-05	0.00024	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—malignant glioma	9.9e-05	0.000239	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—malignant glioma	9.89e-05	0.000239	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—malignant glioma	9.69e-05	0.000234	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—malignant glioma	9.6e-05	0.000232	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—malignant glioma	9.58e-05	0.000232	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—malignant glioma	9.49e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—malignant glioma	9.49e-05	0.000229	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—malignant glioma	9.48e-05	0.000229	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—malignant glioma	9.45e-05	0.000228	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—malignant glioma	9.43e-05	0.000228	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MDM2—malignant glioma	9.41e-05	0.000228	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAF1—malignant glioma	9.38e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—malignant glioma	9.36e-05	0.000226	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—malignant glioma	9.3e-05	0.000225	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF2—malignant glioma	9.28e-05	0.000224	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—malignant glioma	9.28e-05	0.000224	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—malignant glioma	9.15e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—malignant glioma	9.08e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—malignant glioma	8.97e-05	0.000217	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—malignant glioma	8.92e-05	0.000216	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—malignant glioma	8.8e-05	0.000213	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—malignant glioma	8.72e-05	0.000211	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—malignant glioma	8.7e-05	0.00021	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MDM2—malignant glioma	8.68e-05	0.00021	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—malignant glioma	8.66e-05	0.000209	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAF1—malignant glioma	8.65e-05	0.000209	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—malignant glioma	8.56e-05	0.000207	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—malignant glioma	8.5e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—malignant glioma	8.45e-05	0.000204	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—malignant glioma	8.42e-05	0.000204	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—malignant glioma	8.41e-05	0.000203	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—malignant glioma	8.4e-05	0.000203	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—malignant glioma	8.38e-05	0.000203	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—malignant glioma	8.32e-05	0.000201	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—malignant glioma	8.12e-05	0.000196	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—malignant glioma	8.06e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—malignant glioma	7.98e-05	0.000193	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—malignant glioma	7.96e-05	0.000192	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—malignant glioma	7.91e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—malignant glioma	7.84e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—malignant glioma	7.77e-05	0.000188	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—malignant glioma	7.76e-05	0.000188	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—malignant glioma	7.73e-05	0.000187	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—malignant glioma	7.72e-05	0.000187	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—malignant glioma	7.56e-05	0.000183	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—malignant glioma	7.41e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—malignant glioma	7.34e-05	0.000178	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—malignant glioma	7.3e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—malignant glioma	7.25e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—malignant glioma	7.15e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—malignant glioma	7.14e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—malignant glioma	7.12e-05	0.000172	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—malignant glioma	7.07e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—malignant glioma	7.07e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—malignant glioma	6.85e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—malignant glioma	6.59e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—malignant glioma	6.57e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—malignant glioma	6.56e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—malignant glioma	6.53e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—malignant glioma	6.43e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—malignant glioma	6.35e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—malignant glioma	6.29e-05	0.000152	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—malignant glioma	6.09e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—malignant glioma	6.07e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—malignant glioma	6.07e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—malignant glioma	5.93e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—malignant glioma	5.61e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—malignant glioma	5.58e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—malignant glioma	5.4e-05	0.000131	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—malignant glioma	5.36e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—malignant glioma	5.15e-05	0.000125	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—malignant glioma	5.14e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—malignant glioma	4.98e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—malignant glioma	4.56e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—malignant glioma	4.21e-05	0.000102	CbGpPWpGaD
